The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups
Open accessAbstract
Schizophrenia is characterized by physical (mainly metabolic and cardiovascular) comorbidity and shortened lifespan. High sensitivity C-reactive protein (hs-CRP), an inflammatory marker of hepatic origin linked to metabolic and cardiovascular diseases and mortality in the general population, has been reported to be elevated in people with schizophrenia. However, the relationship of hs-CRP to psychiatric and medical risk factors, after controlling for potentially confounding variables such as smoking, is not well established in schizophrenia. We assessed hs-CRP levels along with various demographic, psychiatric, and metabolic measures in 88 clinically stable outpatients with schizophrenia or schizoaffective disorder and 71 age epoch-matched comparison subjects with no history of a major psychiatric illness. hs-CRP levels were significantly higher in individuals with schizophrenia than in comparison subjects. Higher hs-CRP levels in the schizophrenia group were associated with female gender, more severe negative symptoms, greater medical comorbidity, and worse metabolic risk factors including BMI, fasting glucose, and hemoglobin A1c levels. hs-CRP was not related to age, race, education, smoking status, antipsychotic dosage, or cognitive impairment. Longitudinal studies are needed to investigate the relationship between hs-CRP and long-term health outcomes including metabolic syndrome, cardiovascular disease, and mortality in schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and used in clinical practice mainly as a biomarker of infection, chronic disease state, and chronic low-grade inflammation [30,32].”
From C-Reactive protein as a biomarker for major depressive disorder? (2022) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 4,694
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
Scale for the Assessment of Negative Symptoms (SANS)*
(1989) · The British Journal of Psychiatry · doi:10.1192/s0007125000291502 · Cited by 2,710
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513
Scale for Assessment of Positive Symptoms (SAPS) 1984
Andreasen, N. C. (1995) · Open Scholarship Institutional Repository (Washington University in St. Louis) · Cited by 2,423
Scale for the Assessment of Negative Symptoms
Andreasen, N. C. (1982) · PsycTESTS Dataset · doi:10.1037/t12696-000 · Cited by 1,888
Black, S., Kushner, I., & Samols, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400025200 · Cited by 1,844
Shunk, A. W., Davis, A. S., & Dean, R. S. (2006) · Applied Neuropsychology · doi:10.1207/s15324826an1304_9 · Cited by 1,540
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488
Flagged first, then by citations
Cited by
Sorted by citations
Lee, E. E., Depp, C., Palmer, B. W., Glorioso, D., Daly, R., Liu, J., Tu, X. M., Kim, H.-C., Tarr, P., Yamada, Y., et al. (2019) · International Psychogeriatrics · doi:10.1017/s1041610218002120 · Cited by 286
Self-citationSocioeconomic status and inflammation: a meta-analysis
Muscatell, K. A., Brosso, S. N., & Humphreys, K. L. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0259-2 · Cited by 294
Nguyen, T. T., Kosciolek, T., Maldonado, Y., Daly, R. E., Martin, A. S., McDonald, D., Knight, R., & Jeste, D. V. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2018.09.014 · Cited by 260
Self-citationMisiak, B., Stańczykiewicz, B., Kotowicz, K., RYBAKOWSKI, J. K., Samochowiec, J., & Frydecka, D. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.04.015 · Cited by 209
C-Reactive protein as a biomarker for major depressive disorder?
Orsolini, L., Pompili, S., Tempia Valenta, S., Salvi, V., & Volpe, U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031616 · Cited by 171
Bora, E. (2019) · Psychological Medicine · doi:10.1017/s0033291719001685 · Cited by 150
Neuroinflammation in schizophrenia: the role of nuclear factor kappa B
Murphy, C. E., Walker, A. K., & Weickert, C. S. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01607-0 · Cited by 128
Patlola, S. R., Donohoe, G. J., & McKernan, D. P. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110668 · Cited by 122
Lee, E. E., Hong, S., Martin, A. S., Eyler, L. T., & Jeste, D. V. (2017) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.09.009 · Cited by 94
Self-citationProtein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review
Orsolini, L., Sarchione, F., Vellante, F., Fornaro, M., Matarazzo, I., Martinotti, G., Valchera, A., Nicola, M. D., Carano, A., Giannantonio, M. D., et al. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180119144538 · Cited by 102
Bulzacka, E., Boyer, L., Schürhoff, F., Godin, O., Berna, F. S., Brunel, L., Andrianarisoa, M., Aouizerate, B., Capdevielle, D., Chéreau, I., et al. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw029 · Cited by 99
Joseph, J., Depp, C. A., Shih, P.-A. B., Cadenhead, K. S., & Schmid‐Schönbein, G. W. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00155 · Cited by 95
Self-citationCampeau, A., Mills, R. H., Stevens, T. W., Rossitto, L.-A. M., Meehan, M. J., Dorrestein, P. C., Daly, R., Nguyen, T. T., Gonzalez, D. J., Jeste, D. V., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01339-z · Cited by 93
Self-citationC-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review
Fond, G. B., Lançon, C., Auquier, P., & Boyer, L. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00392 · Cited by 95
Lyall, A. E., Pasternak, O., Robinson, D. G., Newell, D., Trampush, J. W., Gallego, J. A., D, M. F. M., Malhotra, A. K., Karlsgodt, K. H., Kubicki, M. R., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.43 · Cited by 93
Abnormalities in chemokine levels in schizophrenia and their clinical correlates
Hong, S., Lee, E., Martin, A. S., Soontornniyomkij, B., Soontornniyomkij, V., Achim, C. L., Reuter, C., Irwin, M. R., Eyler, L. T., & Jeste, D. V. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.09.019 · Cited by 91
Self-citationMorrens, M., Overloop, C., Coppens, V., Loots, E., Noortgate, M. V. D., Vandenameele, S., Leboyer, M., & Picker, L. D. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01582-y · Cited by 72
Abnormal levels of vascular endothelial biomarkers in schizophrenia
Nguyen, T. T., Dev, S. I., Chen, G., Liou, S. C., Martin, A. S., Irwin, M. R., Carroll, J., Tu, X. M., Jeste, D. V., & Eyler, L. T. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0842-6 · Cited by 66
Self-citationChildhood Adversity and Schizophrenia
Lee, E., Martin, A. S., Tu, X. M., Palmer, B. W., & Jeste, D. V. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17m11776 · Cited by 64
Self-citationSleep disturbances and inflammatory biomarkers in schizophrenia: focus on sex differences
Lee, E. E., Ancoli-Israel, S., Eyler, L. T., Tu, X. M., Palmer, B. W., Irwin, M. R., & Jeste, D. V. (2019) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.09.017 · Cited by 58
Self-citationNettis, M. A., Pergola, G., Kolliakou, A., O’Connor, J. A., Bonaccorso, S., David, A. S., Gaughran, F., Forti, M. D., Murray, R. M., Marques, T. R., et al. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.09.005 · Cited by 56
García-Álvarez, L., Caso, J. R., García‐Portilla, M. P., de la Fuente-Tomás, L., González-Blanco, L., Sáiz, P. A., Leza, J. C., & Bobes, J. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.09.007 · Cited by 56
Psomiades, M., Fonteneau, C., Mondino, M., Luck, D., Haesebaert, F., Suaud‐Chagny, M., & Brunelin, J. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.04.013 · Cited by 52
iTRAQ technology-based identification of human peripheral serum proteins associated with depression
Wang, Q., Su, X., Jiang, X., Dong, X., Fan, Y., Zhang, J., Yu, C., Gao, W., Shi, S., Jiang, J., et al. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.05.055 · Cited by 49
Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention
Wang, Y., Meng, W., Liu, Z., An, Q., & Hu, X. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1046692 · Cited by 51
Leukocyte telomere length: Effects of schizophrenia, age, and gender
Wolkowitz, O. M., Jeste, D. V., Martin, A. S., Lin, J., Daly, R. E., Reuter, C., & KRAEMER, H. C. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.10.015 · Cited by 49
Self-citationMisiak, B., Łaczmański, Ł., Słoka, N. K., Szmida, E., Piotrowski, P., Loska, O., Ślężak, R., Kiejna, A., & Frydecka, D. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.01.077 · Cited by 48
A significant causal association between C-reactive protein levels and schizophrenia
Inoshita, M., Numata, S., Tajima, A., Kinoshita, M., Umehara, H., Nakataki, M., Ikeda, M., Maruyama, S., Yamamori, H., Kanazawa, T., et al. (2016) · Scientific Reports · doi:10.1038/srep26105 · Cited by 42
RetractedLee, E., Winston-Gray, C., Barlow, J. W., Rissman, R. A., & Jeste, D. V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.532624 · Cited by 39
Self-citationZhang, Q., Hong, W., Li, H., Peng, F., Wang, F., Li, N., Xiang, H., Zhang, Z., Su, Y., Huang, Y., et al. (2017) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2017.02.001 · Cited by 39
Fond, G. B., Resseguier, N., Schürhoff, F., Godin, O., Andrianarisoa, M., Brunel, L., Bulzacka, E., Aouizerate, B., Berna, F. S., Capdevielle, D., et al. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0847-1 · Cited by 39
Kozłowska, E., Agier, J., Wysokiński, A., Łucka, A., Sobierajska, K., & Brzezińska‐Błaszczyk, E. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.138 · Cited by 37
Sapra, M., Lawson, D. M., Iranmanesh, A., & Varma, A. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.04.051 · Cited by 33
Relation of inflammatory markers with symptoms of psychotic disorders: a large cohort study
Liemburg, E. J., Nolte, I. M., Klein, H. C., & Knegtering, H. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.04.006 · Cited by 32
Decreased Serum Oxytocin and Increased Homocysteine in First-Episode Schizophrenia Patients
Liu, Y., Tao, H., Yang, X., Huang, K., Zhang, X., & Li, C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00217 · Cited by 32
Elevated plasma F2-isoprostane levels in schizophrenia
Lee, E., Eyler, L. T., Wolkowitz, O. M., Martin, A. S., Reuter, C., KRAEMER, H. C., & Jeste, D. V. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.06.011 · Cited by 31
Self-citationWei, L., Du, Y., Wu, W., Fu, X., & Xia, Q. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.10.002 · Cited by 31
Bahrami, A., Bahrami‐Taghanaki, H., Khorasanchi, Z., Tayefi, M., Ferns, G. A., Sadeghnia, H. R., & Ghayour‐Mobarhan, M. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01288-x · Cited by 21
Improvement of adjunctive berberine treatment on negative symptoms in patients with schizophrenia
Li, M., Qiu, Y., Zhang, J., Zhang, Y., Liu, Y., Zhao, Y., Jia, Q., Fan, X., & Li, J. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01359-4 · Cited by 21
Bolu, A., Aydın, M. S., Akgün, A., Coşkun, A., Garip, B., Öznur, T., Çelik, C., & Uzun, Ö. (2019) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2019.17.2.244 · Cited by 21
Soontornniyomkij, V., Lee, E. E., Jin, H., Martin, A., Daly, R., Liu, J., Tu, X., Eyler, L., & Jeste, D. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00251 · Cited by 19
Self-citationPan, L.-H., Qian, M. D., Qu, W., Tang, Q., & Yan, Y. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s284149 · Cited by 18
Adamowicz, D. H., Shilling, P. D., Palmer, B. W., Nguyen, T. T., Wang, E., Liu, C., Tu, X. M., Jeste, D. V., Irwin, M. R., & Lee, E. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.02.029 · Cited by 17
Self-citationLee, E. E., Martin, A., Kaufmann, C. N., Liu, J., Kangas, J. L., Daly, R., Tu, X., Depp, C., & Jeste, D. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.02.067 · Cited by 18
Self-citationC-Reactive Protein (CRP): A Potent Inflammation Biomarker in Psychiatric Disorders
Orsolini, L., Pompili, S., & Volpe, U. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_7 · Cited by 19
Nishimon, S., Ohnuma, T., Takebayashi, Y., Katsuta, N., Takeda, M., Nakamura, T., Sannohe, T., Higashiyama, R. I., Kimoto, A., Shibata, N., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.03.006 · Cited by 16
Klaus, F., Guetter, K., Schlegel, R., Spiller, T. R., Seifritz, E., Cathomas, F., & Kaiser, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-98769-0 · Cited by 17
Zeng, J., Zhang, W., Lu, X., Zhou, H., Huang, J. H., Xu, Z., Liao, H., Liang, J., Liang, M., Ye, C., et al. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01679-7 · Cited by 15
Plasma GDF15 level is elevated in psychosis and inversely correlated with severity
Kumar, P., Millischer, V., Villaescusa, J. C., Nilsson, I. A. K., Östenson, C., Schalling, M., Ösby, U., & Lavebratt, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-07503-2 · Cited by 16
Boozalis, T., Devaraj, S., & Okusaga, O. O. (2018) · Psychiatric Quarterly · doi:10.1007/s11126-018-9606-3 · Cited by 15
Tang, S. X., Oliver, L. D., Hänsel, K., DeRosse, P., John, M., Khairullah, A., Gold, J. M., Buchanan, R. W., Voineskos, A. N., & Malhotra, A. K. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02002-z · Cited by 15
Pan, S., Tan, Y., Yao, S., Zhao, X., & Xiong, J. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.09.033 · Cited by 15
Fathian, F., Gjestad, R., Kroken, R. A., Løberg, E., Reitan, S. K., Fleichhacker, W. W., Rettenbacher, M. A., Larsen, T. K., Joa, I., Stabell, L. A., et al. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.01.049 · Cited by 15
Challa, F., Seifu, D., Sileshi, M., Getahun, T., Geto, Z., Kassa, D., Alemayehu, M., Mesfin, M., Fekadu, A., & Woldeamanuel, Y. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03443-4 · Cited by 14
Orsolini, L., Ricci, L., Pompili, S., Cicolini, A., & Volpe, U. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.04.004 · Cited by 14
González-Blanco, L., García‐Portilla, M. P., García-Álvarez, L., de la Fuente-Tomás, L., García, C. I., Sáiz, P. A., & Bobes, J. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.08.042 · Cited by 12
Galectin-1 and Galectin-3 Levels in Patients with Schizophrenia and their Unaffected Siblings
Yüksel, R. N., Göverti, D., Kahve, A. C., Çakmak, I. B., Yücel, Ç., & Göka, E. (2020) · Psychiatric Quarterly · doi:10.1007/s11126-020-09731-8 · Cited by 12
Milewski, K. P., Żurakowski, A., Pająk, J., Pajak-Zielinska, E., Liszka, Ł., Buszman, P. P., Bis, J., Dębiński, M., & Buszman, P. E. (2010) · PubMed · Cited by 11
Santo, F. D., González-Blanco, L., García-Álvarez, L., de la Fuente-Tomás, L., Velasco, Á., Alvarez-Vázquez, C., Martínez-Cao, C., Sáiz, P. A., García‐Portilla, M. P., & Bobes, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-73043-x · Cited by 12
Cannabis Cessation, Inflammatory Markers and Schizophrenia
Roméo, B., Lestra, V., Martelli, C., Benyamina, A., & Hamdani, N. (2022) · Journal of Dual Diagnosis · doi:10.1080/15504263.2021.2013697 · Cited by 11
Interplay of inflammatory biomarkers in heart disease patients with depressive symptoms: An update
Varghese, T. P., Chand, S., Varghese, N. M., Singh, R., & Yadav, S. K. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102352 · Cited by 12
Chang, C.-H., Lane, H., Liu, C., Cheng, P.-C., Chen, S.-J., & Lin, C. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s223278 · Cited by 11
Palmer, B. W., Moore, R. C., Eyler, L. T., Pinto, L. L., Saks, E. R., & Jeste, D. V. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.07.052 · Cited by 10
Self-citationWhat can we learn about brain donors? Use of clinical information in human postmortem brain research
Sullivan, K., Pantazopoulos, H., Liebson, E. S., Woo, T., Baldessarini, R. J., Hedreen, J. C., & Berretta, S. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63639-3.00014-1 · Cited by 8
Zhu, J., Hu, W., Zhou, Y., Qiao, J., Chang, X., & Tong, Z. (2019) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2019.152118 · Cited by 10
Oracz, A. J., Zwierz, M., Naumowicz, M., Modzelewski, S., Suprunowicz, M., & Waszkiewicz, N. (2025) · Biomedicines · doi:10.3390/biomedicines13092308 · Cited by 9
Berdeville, C. H. D. S. F., Silva-Amaral, D., Dalgalarrondo, P., Banzato, C. E. M., & Martins‐de‐Souza, D. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105949 · Cited by 9
Levihn‐Coon, A., Smits, J. A. J., & Beevers, C. G. (2025) · PLOS mental health. · doi:10.1371/journal.pmen.0000211 · Cited by 8
Adamowicz, D. H., Wu, T., Daly, R., Irwin, M. R., Jeste, D. V., Tu, X. M., Eyler, L. T., & Lee, E. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110866 · Cited by 7
Self-citationQuality of Life and C-Reactive Protein in Patients with Schizophrenia: A Cross-Sectional Study
Kachouchi, A., Laatabi, A., Saadia, K., Imane, A., & Fatiha, M. (2024) · ALPHA PSYCHIATRY · doi:10.5152/alphapsychiatry.2024.231437 · Cited by 7
Nimgaonkar, V. L., Dickerson, F., Pouget, J. G., Chowdari, K. V., O’Dushlaine, C. T., Wood, J. A., Klei, L., Devlin, B., & Yolken, R. H. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.12.025 · Cited by 6
Ferns, G. A. (2018) · Translational Metabolic Syndrome Research · doi:10.1016/j.tmsr.2018.04.003 · Cited by 9
Wysokiński, A., Socha, K., Sołtysik, B. K., Kłoszewska, I., Sobów, T., & Kostka, T. (2016) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2016.1174298 · Cited by 5
Longitudinal relationships between BMI and hs-CRP among people with schizophrenia
Dyne, A. V., Wu, T., Adamowicz, D. H., Lee, E., Tu, X. M., & Eyler, L. T. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.07.050 · Cited by 5
Kozłowska, E., Żelechowska, P., Wysokiński, A., Rasmus, P., Łucka, A., & Brzezińska‐Błaszczyk, E. (2019) · Journal of Investigative Medicine · doi:10.1136/jim-2018-000964 · Cited by 5
Kachouchi, A., Sebbani, M., Akammar, S., Berghalout, M., Adali, I., Manoudi, F., Amine, M., & Asri, F. (2020) · L Encéphale · doi:10.1016/j.encep.2019.11.007 · Cited by 5
Ayari, F., Chaaben, A. B., Ammar, H. B., Nefzi, R., Ouni, N., Mihoub, O., Abaza, H., Aissa, A., Douik, H., Gara, S., et al. (2020) · L Encéphale · doi:10.1016/j.encep.2019.10.001 · Cited by 5
Ramsey, M., Govind, T., Lam, J. A., Palmer, B. W., Jeste, D. V., & Lee, E. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.03.017 · Cited by 5
Self-citationPeripheral immune cell markers and cognitive function in patients with schizophrenia
Karahan, A., Saka, I. M., Aykut, D. S., Arslan, F. C., Özmen, E. S., & Karagüzel, E. Ö. (2024) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174241266059 · Cited by 5
Demir, N., & Yildirim, O. A. (2023) · Psychiatry and Clinical Psychopharmacology · doi:10.5152/pcp.2022.22447 · Cited by 3
Kozłowska, E., Brzezińska‐Błaszczyk, E., Wysokiński, A., & Żelechowska, P. (2021) · Journal of Investigative Medicine · doi:10.1136/jim-2020-001523 · Cited by 3
Familial Mediterranean fever association with schizophrenia: insights from big data analysis
Sharif, Κ., Watad, ., Bragazzi, N. L., Yavne, Y., Bridgewood, C., McGonagle, D., Comanhester, D., Cohen, A. D., & Amital, H. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.95463 · Cited by 3
C-Reactive Protein and Aggression in Patients with Schizophrenia
Kachouchi, A. (2019) · International Journal of Psychological and Brain Sciences · doi:10.11648/j.ijpbs.20190402.11 · Cited by 3
Mourad, B. H. (2020) · Toxicology and Industrial Health · doi:10.1177/0748233720923504 · Cited by 3
Characterization of Anemia among Hospitalized Patients with Psychiatric Disorders
Ali, E., Zaitoun, N. A., Embaby, A., Zaitoun, N. A., & Ibrahim, D. (2022) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2022.271901 · Cited by 2
Schizophrenia spectrum disorders
(2023) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-323-91771-1.00008-3 · Cited by 2
Arya, S., Kamyab, A., Sanatkar, S. A., Pourmehdiardebili, M., Ebrahimi, A., Kamyab, P., Alavi, K., Zarei, Z., & Ahmadkhaniha, H. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05234-5 · Cited by 3
Sommerfeld, D. H., Brunner, A., Glorioso, D., Lee, E., Ibarra, C., Zunshine, E., Daly, R. E., Zoumas, C., & Jeste, D. V. (2022) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-022-01189-z · Cited by 2
Self-citationSakai, Y., Larsen, J. B., & Reitan, S. K. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e08992 · Cited by 2
Su, Q., Wang, J., Ge, H., Li, M., Sun, X., Wang, S., Xuekelaiti, Z., Feng, Z., Xu, Y., Qiu, Y., et al. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116604 · Cited by 1
Lee, J.-Y., Liu, Y.-H., Hsieh, C. L., & Lung, F. (2025) · Science Progress · doi:10.1177/00368504251405328 · Cited by 1
Chapter 11. Schizophrenia Spectrum and Other Psychotic Disorders
Graham, S. A., Adamowicz, D. H., Jeste, D. V., & Lee, E. (2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375196.ds11 · Cited by 1
Self-citationHeil, M., Edlinger, M., Biedermann, F., Schurr, T., & Hofer, A. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1644428 · Cited by 2
Exploring the link between inflammation and mental disorders
Effendy, E. (2018) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/125/1/012187 · Cited by 1
Oxidative Stress Index and Peripheral Biomarkers for Schizophrenia: A Revisited Approach.Preprint
Wasti, A. Z., Jabeen, F., Rasheed, S., Shah, N., Khan, D., Zehra, Z., Aziz, F., Riaz, A., Ahmed, S. L., Ahmed, N., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3879201/v1 · Cited by 1
Response to Xuerong Luo et al., Letter to the Editor
Aas, M. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.07.006
Liu, J., He, Y., & Luo, X. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.07.007
Biological Changes in Older People with Schizophrenia
Centorino, M. B., & Schultz, S. K. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108539593.006
Mahmuddin, P. M., Effendy, E., & Amin, M. M. (2021) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2021.6305
A literature survey on the biomarkers of cardiovascular disease
Pavithra, R., Sangeetha, T., Velayuthaprabhu, S., & Anand, A. V. (2021) · International Journal of Academic Medicine · doi:10.4103/ijam.ijam_80_20
Metadata
- Authors
- Joseph, J., Depp, C., Martin, A. S., Daly, R. E., Glorioso, D. K., Palmer, B. W., & Jeste, D. V.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Jeste, Dilip V.
- ORCID
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 168
- Issue
- 1-2
- Pages
- 456-460
- ISSN
- 0920-9964 (ISSN-L)
- PMC
- PMC4591213
- OpenAlex
- W2142231500
- Cited by
- 109
- References
- 55
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 5 · 2023: 9 · 2022: 14 · 2021: 8 · 2020: 8 · 2019: 11 · 2018: 15 · 2017: 15 · 2016: 13
- FWCI
- 11.62
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Schizophrenia Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Mental Health (MH019934, R01MH094151, T32MH019934)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- high-sensitivity C-reactive protein, schizophrenia
- MeSH terms
- Adult, Aged, C-Reactive Protein, Female, Humans, Longitudinal Studies, Male, Metabolic Diseases, Middle Aged, Outpatients, Psychotic Disorders, Risk Factors, Schizophrenia, Sex Characteristics, Biomarkers, Comorbidity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
